Page 4 - Sumit Sinha News Today

Aflac Ventures, Digital Horizon, Stride Ventures, and existing investors also participated in the round Funds will be used to strengthen full-stack and value-driven chronic care ecosystem, accelerate market expansion, customer acquisition, building new revenue streams Increases PhableCares valuation by 6x Bengaluru headquartered, PhableCare, Indias largest chronic disease management company, has raised Series B funding of INR 187 crores USD 25 Million within one year of raising Series A.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Phablecare has acquired Fused Training, a Type-1 Diabetes health management startup to strengthen its Type-1 Diabetes vertical. 

/PRNewswire/ -- Phablecare, one of Indias leading Health-tech players focusing on chronic disease management, announced today the acquisition of Fused...

The round of Phable further saw participation from Aflac Ventures, SOSV, Omron Ventures, Stride Ventures, among others.

The Supreme Court on Thursday dismissed a plea seeking an injunction against the Bollywood movie Gangubai Kathiawadi.

The Supreme Court suggested that the name of Sanjay Leela Bhansali's movie Gangubai Kathiawadi be changed in light of several cases seeking to stay its release.

New York (PRWEB) December 22, 2021 -- The Healthcare Technology Report is pleased to announce The Top 25 Consumer HealthTech Executives of 2021. This year,

Share Mandi: A research team at the Indian Institute of Technology Mandi, led by Dr. Sumit Sinha Ray, Assistant Professor, School of Engineering, has developed a fibrous membrane filter using a biopolymer-based material to remove heavy metals from water. The results of this research have recently been published in the prestigious Elsevier journal, Polymer. The paper has been co-authored by Dr. Sinha Ray and his research scholar, Mr. Ashish Kakoria, along with Dr. Suman Sinha Ray, Adjunct Assist...

Phable, a Bengaluru-based healthtech platform focused on chronic disease management, last week announced a $12M Series A investment round.